ABSTRACT
Objective Environmental disasters are anthropogenic catastrophic events that affect health. Famous disasters include the Chernobyl and Fukushima-Daiichi nuclear meltdowns, which had disastrous health consequences. Traditional methods for studying environmental disasters are costly and time-intensive. We propose the use of Electronic Health Records (EHR) and informatics methods to study the health effects of emergent environmental disasters in a cost-effective manner.
Materials and Methods An emergent environmental disaster is exposure to Perfluoralkyl Substances (PFAS) in the Philadelphia area. Penn Medicine (PennMed) comprises multiple hospitals and facilities within the Philadelphia Metropolitan area, including over three thousand PFAS-exposed women living in one of the highest PFAS exposure areas nationwide. We developed a high-throughput method that utilizes only EHR data to evaluate the disease risk in this heavily exposed population.
Results We replicated all five disease/conditions implicated by PFAS exposure, including hypercholesterolemia, proteinuria, thyroid disease, kidney disease and colitis, either directly or via closely related diagnoses.
Discussion Using EHRs coupled with informatics enables the health impacts of environmental disasters to be more easily studied in large cohorts versus traditional methods that rely on interviews and expensive serum-based testing. By reducing cost and increasing the diversity of individuals included in studies, we can overcome many of the hurdles faced by previous studies, including a lack of racial and ethnic diversity.
Conclusion This proof-of-concept study confirms that EHRs can be used to study human health and disease impacts of environmental disasters and produces equivalent disease-exposure knowledge to prospective epidemiology studies while remaining cost-effective.
KEY MESSAGES
Electronic Health Records can be used for studying health effects of environmental exposures
PFAS exposure - disease associations were mainly replicated using EHRs
EHRs represent a cost-effective method to augment traditional epidemiology studies
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We thank the Perelman School of Medicine at the University of Pennsylvania for generous funds to support this project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Pennsylvania's Institutional Review Board approved this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This paper uses Electronic Health Records data (EHR) obtained from the PennMedicine health system. This data is not freely available or shareable due to patient privacy concerns. Therefore the 'raw' patient data is not shareable. However, we are sharing our results in this paper and our methods are described.
